RaySearch Laboratories AB (publ)
RAY-B
Rank in Stocks
#11266
RaySearch Laboratories AB (publ) is a global medical technology company... RaySearch Laboratories AB (publ) is a global medical technology company dedicated to developing cutting-edge software solutions for cancer treatment. Its principal offering, RayStation, is a sophisticated treatment planning system that supports a vast range of clinical activities. These capabilities include automated planning, adaptive therapy, multi-criteria optimization, rapid and accurate dose calculations, OAR dose reduction, robustness modeling, machine learning integration, and support for advanced radiation modalities such as VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic treatments, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also offers RayPlan, another treatment planning system specifically designed for various radiation therapy methods including 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy. For managing oncology workflows, RayCare serves as a dedicated information system. Additionally, RaySearch provides RayCommand, a flexible treatment control system compatible with diverse hardware and designed to manage advanced functionalities of treatment machines and software. To leverage patient data, its cloud-based oncology analytics system, RayIntelligence, converts raw information into valuable insights. RaySearch Laboratories AB (publ) further provides training courses for its products and is headquartered in Stockholm, Sweden.
Share Price
$17.57
Last synced: 2026-11-09
Market Cap
$584.82M
Change (1 day)
-1.65%
Change (1 year)
-25.71%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade RaySearch Laboratories AB (publ) (RAY-B)
Category
Healthcare
EPS for RaySearch Laboratories AB (publ) (RAY-B)
EPS as of September 2026 TTM: $0.61
According to RaySearch Laboratories AB (publ)'s latest financial reports, its current EPS (TTM) is $0.61. At the end of 2025 the company had an EPS of $0.72, an increase over its 2024 EPS of $0.54.
EPS history for RaySearch Laboratories AB (publ) from 2003 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.61 | -15.61% |
| 2025 | $0.72 | 33.81% |
| 2024 | $0.54 | 128.32% |
| 2023 | $0.24 | 256.34% |
| 2022 | $0.07 | -143.41% |
| 2021 | $-0.15 | 384.13% |
| 2020 | $-0.03 | -120.00% |
| 2019 | $0.16 | -38.55% |
| 2018 | $0.26 | -38.90% |
| 2017 | $0.42 | -13.77% |
| 2016 | $0.49 | 100.12% |
| 2015 | $0.24 | 8.43% |
| 2014 | $0.22 | -336.75% |
| 2013 | $-0.09 | -206.29% |
| 2012 | $0.09 | 22.73% |
| 2011 | $0.07 | -42.01% |
| 2010 | $0.13 | 1.54% |
| 2009 | $0.12 | 82.40% |
| 2008 | $0.07 | -24.97% |
| 2007 | $0.09 | -41.72% |
| 2006 | $0.15 | 44.62% |
| 2005 | $0.11 | 72.98% |
| 2004 | $0.06 | -378.38% |
| 2003 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.86 | 535.29% |
US
|
|
| $1.64 | 169.91% |
US
|
|
| $-1.05 | -272.81% |
US
|
|
| $1.79 | 194.98% |
AU
|
|
| $2.08 | 242.33% |
US
|
Questions about RaySearch Laboratories AB (publ)'s earnings per share (EPS)
What is RaySearch Laboratories AB (publ)'s earnings per share (EPS)?
RaySearch Laboratories AB (publ)'s earnings per share (EPS) over the last twelve months is $0.61, as of Sep 2026.
What was RaySearch Laboratories AB (publ)'s earnings per share (EPS) in 2025?
In 2025, RaySearch Laboratories AB (publ)'s earnings per share (EPS) was $0.72, 33.33% more than in 2024 ($0.54).
How has RaySearch Laboratories AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, RaySearch Laboratories AB (publ)'s earnings per share (EPS) was highest in 2025 ($0.72) and lowest in 2021 ($-0.15).
How does RaySearch Laboratories AB (publ)'s earnings per share (EPS) compare with similar companies?
RaySearch Laboratories AB (publ)'s earnings per share (EPS) ($0.61) is higher than that of 1 of the 5 similar companies listed above. The highest among them is GE HealthCare Technologies Inc., with $3.86.